WallStreetZenWallStreetZen

NASDAQ: XRTX
Xortx Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for XRTX

Based on 1 analyst offering 12 month price targets for Xortx Therapeutics Inc.
Min Forecast
$14.00+440.54%
Avg Forecast
$14.00+440.54%
Max Forecast
$14.00+440.54%

Should I buy or sell XRTX stock?

Based on 1 analyst offering ratings for Xortx Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XRTX stock forecasts and price targets.

XRTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-04

1 of 1

XRTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XRTX$2.59$14.00+440.54%Strong Buy
ATXI$0.12$56.25+47,976.92%Strong Buy
GTBP$3.75N/AN/A
HOTH$1.17$5.50+370.09%Strong Buy
PXMD$0.70$3.00+326.14%Buy

Xortx Therapeutics Stock Forecast FAQ

Is Xortx Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: XRTX) stock is to Strong Buy XRTX stock.

Out of 1 analyst, 1 (100%) are recommending XRTX as a Strong Buy, 0 (0%) are recommending XRTX as a Buy, 0 (0%) are recommending XRTX as a Hold, 0 (0%) are recommending XRTX as a Sell, and 0 (0%) are recommending XRTX as a Strong Sell.

If you're new to stock investing, here's how to buy Xortx Therapeutics stock.

What is XRTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year XRTX price target, the average XRTX price target is $14.00, with the highest XRTX stock price forecast at $14.00 and the lowest XRTX stock price forecast at $14.00.

The Wall Street analyst predicted that Xortx Therapeutics's share price could reach $14.00 by Jan 4, 2025. The average Xortx Therapeutics stock price prediction forecasts a potential upside of 440.54% from the current XRTX share price of $2.59.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.